SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 156 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $122,000 | -10.9% | 94,911 | -12.0% | 0.00% | – |
Q4 2021 | $137,000 | -46.7% | 107,860 | -8.7% | 0.00% | – |
Q3 2021 | $257,000 | -40.8% | 118,140 | +1.8% | 0.00% | – |
Q2 2021 | $434,000 | +22.9% | 116,073 | +7.0% | 0.00% | – |
Q1 2021 | $353,000 | -9.0% | 108,455 | -4.7% | 0.00% | – |
Q4 2020 | $388,000 | -11.0% | 113,782 | +6.6% | 0.00% | – |
Q3 2020 | $436,000 | -73.9% | 106,756 | -78.4% | 0.00% | -100.0% |
Q2 2020 | $1,669,000 | +52.0% | 494,031 | +4.8% | 0.00% | 0.0% |
Q1 2020 | $1,098,000 | +84.5% | 471,329 | +187.4% | 0.00% | – |
Q4 2019 | $595,000 | -69.2% | 164,004 | -29.6% | 0.00% | -100.0% |
Q3 2019 | $1,931,000 | -72.6% | 232,944 | -71.5% | 0.00% | -75.0% |
Q2 2019 | $7,046,000 | +52.9% | 818,530 | +89.8% | 0.00% | +33.3% |
Q1 2019 | $4,608,000 | +29.0% | 431,194 | +5.6% | 0.00% | 0.0% |
Q4 2018 | $3,572,000 | -81.5% | 408,433 | -64.4% | 0.00% | -50.0% |
Q3 2018 | $19,288,000 | +11.0% | 1,148,237 | +38.5% | 0.01% | +20.0% |
Q2 2018 | $17,377,000 | +48.0% | 829,086 | +13.6% | 0.01% | -16.7% |
Q1 2018 | $11,739,000 | +48.3% | 729,690 | +74.7% | 0.01% | +20.0% |
Q4 2017 | $7,915,000 | -38.2% | 417,765 | -54.1% | 0.01% | -44.4% |
Q3 2017 | $12,808,000 | +127.5% | 910,369 | +20.5% | 0.01% | +125.0% |
Q2 2017 | $5,629,000 | +59.3% | 755,723 | +39.0% | 0.00% | +33.3% |
Q1 2017 | $3,534,000 | -35.1% | 543,826 | -55.8% | 0.00% | -25.0% |
Q4 2016 | $5,449,000 | -30.2% | 1,230,669 | -26.4% | 0.00% | -33.3% |
Q3 2016 | $7,807,000 | -31.1% | 1,672,102 | -3.0% | 0.01% | -25.0% |
Q2 2016 | $11,324,000 | +30.4% | 1,723,971 | +26.2% | 0.01% | +14.3% |
Q1 2016 | $8,683,000 | +8.1% | 1,365,667 | +2.5% | 0.01% | +16.7% |
Q4 2015 | $8,030,000 | +34.9% | 1,332,044 | +33.8% | 0.01% | +20.0% |
Q3 2015 | $5,954,000 | +43.5% | 995,890 | +64.1% | 0.01% | +66.7% |
Q2 2015 | $4,150,000 | +36.3% | 606,931 | +21.0% | 0.00% | +50.0% |
Q1 2015 | $3,045,000 | +56.2% | 501,798 | +78.3% | 0.00% | +100.0% |
Q4 2014 | $1,949,000 | -9.3% | 281,481 | +6.5% | 0.00% | 0.0% |
Q3 2014 | $2,150,000 | -27.2% | 264,398 | -27.3% | 0.00% | -50.0% |
Q2 2014 | $2,954,000 | +33.3% | 363,458 | +28.6% | 0.00% | 0.0% |
Q1 2014 | $2,216,000 | +1.9% | 282,727 | +15.0% | 0.00% | 0.0% |
Q4 2013 | $2,174,000 | +89.0% | 245,839 | +78.9% | 0.00% | +100.0% |
Q3 2013 | $1,150,000 | – | 137,428 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,383,466 | $139,917,000 | 12.64% |
ASHFORD CAPITAL MANAGEMENT INC | 362,615 | $6,872,000 | 1.07% |
NEXTHERA CAPITAL LP | 259,300 | $4,914,000 | 0.91% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 639,856 | $12,125,000 | 0.89% |
Sonora Investment Management, LLC | 249,502 | $4,728,063,000 | 0.76% |
Kazazian Asset Management, LLC | 32,526 | $616,000 | 0.63% |
Piermont Capital Management Inc. | 88,372 | $1,675,000 | 0.55% |
J. Goldman & Co LP | 266,479 | $5,050,000 | 0.26% |
J. Goldman & Co LP | 251,500 | $4,766,000 | 0.25% |
Opaleye Management Inc. | 31,000 | $587,000 | 0.19% |